CPRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $14,090,792.06

Catalyst Pharmaceuticals Insider Trading History Chart

Catalyst Pharmaceuticals Share Price & Price History

^$21.81

▼ -0.04 (-0.18%)

As of 07/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Catalyst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/11/2025	Preethi Sundaram	Insider	Sell	1,600	$26.42	$42,272.00	41,081
6/10/2025	Preethi Sundaram	Insider	Sell	2,324	$26.41	$61,376.84	42,681
5/14/2025	Gary Ingenito	Insider	Sell	44,000	$23.63	$1,039,720.00	68,873
5/13/2025	Gary Ingenito	Insider	Sell	200,000	$23.68	$4,736,000.00	68,873
3/5/2025	Gary Ingenito	Insider	Sell	44,904	$22.09	$991,929.36	68,873
3/3/2025	Brian Elsbernd	Insider	Sell	62,975	$22.98	$1,447,165.50	188,564
12/10/2024	Steve Miller	Insider	Sell	50,000	$21.93	$1,096,500.00	686,996
11/27/2024	Gary Ingenito	Insider	Sell	12,000	$22.72	$272,640.00	51,391
11/27/2024	Molly Harper	Director	Sell	17,500	$22.00	$385,000.00
8/21/2024	David S. Tierney	Director	Sell	15,000	$20.10	$301,500.00	348,874
8/20/2024	Steve Miller	Insider	Sell	150,000	$20.35	$3,052,500.00	675,124
8/9/2024	Jeffrey Del Carmen	Insider	Sell	36,058	$18.42	$664,188.36	12,369
6/7/2024	Jeffrey Del Carmen	Insider	Sell	7,541	$16.07	$121,183.87	18,427
6/5/2024	Gary Ingenito	Insider	Sell	80,000	$16.16	$1,292,800.00	51,391
6/4/2024	Richard J. Daly	CEO	Sell	17,323	$15.97	$276,648.31	234,824
6/3/2024	Molly Harper	Director	Sell	5,333	$16.30	$86,927.90
4/8/2024	David S. Tierney	Director	Sell	25,000	$15.68	$392,000.00	348,874
3/27/2024	Brian Elsbernd	Insider	Sell	25,000	$16.44	$411,000.00	124,433
12/12/2023	David S. Tierney	Director	Sell	50,000	$13.32	$666,000.00	333,541
12/11/2023	Alicia Grande	CFO	Sell	60,000	$13.76	$825,600.00	50,557
12/8/2023	Alicia Grande	CFO	Sell	40,000	$14.28	$571,200.00	50,557
12/5/2023	Steve Miller	Insider	Sell	40,000	$14.24	$569,600.00	647,457
5/15/2023	Patrick J. McEnany	CEO	Sell	26,151	$13.23	$345,977.73	3,945,436
4/5/2023	David S. Tierney	Director	Sell	30,000	$16.83	$504,900.00	313,541
3/29/2023	Jeffrey Del Carmen	Insider	Sell	40,000	$16.70	$668,000.00	7,541
3/28/2023	Alicia Grande	CFO	Sell	58,216	$16.54	$962,892.64	50,557
3/22/2023	Alicia Grande	CFO	Sell	41,784	$16.50	$689,436.00	50,557
3/20/2023	Brian Elsbernd	Insider	Sell	50,000	$16.07	$803,500.00	138,076
12/6/2022	Gary Ingenito	Insider	Sell	5,918	$16.85	$99,718.30	30,802
11/23/2022	Philip H. Coelho	Director	Sell	9,999	$17.45	$174,482.55	149,553
11/23/2022	Steve Miller	COO	Sell	20,000	$17.34	$346,800.00	553,791
11/22/2022	Alicia Grande	CFO	Sell	120,000	$16.53	$1,983,600.00	27,442
11/21/2022	Patrick J. McEnany	CEO	Sell	150,000	$15.33	$2,299,500.00	3,902,606
11/21/2022	Philip H. Coelho	Director	Sell	70,000	$15.23	$1,066,100.00	179,553
11/21/2022	Steve Miller	COO	Sell	80,000	$15.28	$1,222,400.00	573,791
11/18/2022	Patrick J. McEnany	CEO	Sell	350,000	$15.62	$5,467,000.00	3,902,606
11/15/2022	Alicia Grande	CFO	Sell	60,000	$15.77	$946,200.00	147,442
11/11/2022	Donald A. Denkhaus	Director	Sell	20,000	$16.59	$331,800.00	277,666
11/11/2022	Preethi Sundaram	insider	Sell	56,786	$16.38	$930,154.68
9/23/2022	Alicia Grande	CFO	Sell	60,000	$11.90	$714,000.00	207,442
9/16/2022	Alicia Grande	CFO	Sell	90,000	$13.50	$1,215,000.00	267,442
9/15/2022	Preethi Sundaram	insider	Sell	18,214	$14.49	$263,920.86	22,053
9/14/2022	Alicia Grande	CFO	Sell	50,000	$15.57	$778,500.00	357,442
9/14/2022	Donald A. Denkhaus	Director	Sell	20,000	$15.34	$306,800.00	297,666
9/13/2022	Patrick J. McEnany	CEO	Sell	80,765	$15.33	$1,238,127.45	4,849,452
9/13/2022	Steve Miller	COO	Sell	107,933	$16.90	$1,824,067.70	653,791
8/29/2022	Alicia Grande	CFO	Sell	57,000	$14.20	$809,400.00	407,442
8/26/2022	Alicia Grande	CFO	Sell	11,095	$14.40	$159,768.00	464,442
8/22/2022	David S. Tierney	Director	Sell	20,000	$14.16	$283,200.00	308,207
8/18/2022	Steve Miller	COO	Sell	150,000	$13.53	$2,029,500.00	761,724
8/17/2022	Alicia Grande	CFO	Sell	130,741	$13.86	$1,812,070.26	475,537

See Full Table

SEC Filings (Institutional Ownership Changes) for Catalyst Pharmaceuticals (NASDAQ:CPRX)

79.22% of Catalyst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Catalyst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/11/2025	BTC Capital Management Inc.	15,145	$0.33M	0.0%	-6.7%	0.012%
7/11/2025	Financiere des Professionnels Fonds d investissement inc.	9,501	$0.21M	0.0%	N/A	0.008%
7/11/2025	Assenagon Asset Management S.A.	104,375	$2.27M	0.0%	+8.0%	0.086%
7/10/2025	Redhawk Wealth Advisors Inc.	67,778	$1.47M	0.2%	+24.7%	0.056%
7/10/2025	Wealth Enhancement Advisory Services LLC	31,755	$0.68M	0.0%	-10.1%	0.026%
7/9/2025	Financiere des Professionnels Fonds d investissement inc.	9,501	$0.21M	0.0%	N/A	0.008%
7/9/2025	Lifestyle Asset Management Inc.	12,454	$0.27M	0.1%	N/A	0.010%
7/8/2025	Juncture Wealth Strategies LLC	91,299	$1.98M	0.7%	-5.0%	0.075%
7/8/2025	Richard P Slaughter Associates Inc	56,880	$1.23M	0.3%	-49.0%	0.047%
7/8/2025	Gallacher Capital Management LLC	15,481	$0.34M	0.2%	-4.6%	0.013%
7/7/2025	Wesbanco Bank Inc.	56,000	$1.22M	0.0%	+194.7%	0.046%
6/23/2025	Swedbank AB	616,132	$14.94M	0.0%	N/A	0.505%
6/18/2025	Voya Investment Management LLC	61,682	$1.50M	0.0%	+17.7%	0.051%
6/5/2025	Cim LLC	25,844	$0.63M	0.1%	-4.4%	0.021%
6/3/2025	Inspire Investing LLC	33,811	$0.82M	0.1%	-12.0%	0.028%
6/2/2025	Cim Investment Management Inc.	8,593	$0.21M	0.0%	N/A	0.007%
5/29/2025	Rhumbline Advisers	310,568	$7.53M	0.0%	-0.6%	0.255%
5/28/2025	Strs Ohio	41,000	$0.99M	0.0%	N/A	0.034%
5/21/2025	Acadian Asset Management LLC	5,251	$0.13M	0.0%	-74.4%	0.004%
5/20/2025	Intech Investment Management LLC	70,087	$1.70M	0.0%	+6.5%	0.057%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	526,297	$12.76M	0.0%	+99.4%	0.431%
5/16/2025	Woodline Partners LP	206,478	$5.01M	0.0%	-18.4%	0.169%
5/16/2025	Fred Alger Management LLC	51,402	$1.25M	0.0%	N/A	0.042%
5/16/2025	Ashton Thomas Private Wealth LLC	13,014	$0.32M	0.0%	+7.4%	0.011%
5/16/2025	Goldman Sachs Group Inc.	3,135,473	$76.04M	0.0%	+11.9%	2.571%
5/16/2025	Teza Capital Management LLC	10,831	$0.26M	0.1%	-48.2%	0.009%
5/16/2025	New Vernon Capital Holdings II LLC	327,860	$7.95M	0.0%	+5,531.4%	0.269%
5/16/2025	Millennium Management LLC	303,533	$7.36M	0.0%	-41.7%	0.249%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	72,052	$1.75M	0.0%	+5.6%	0.059%
5/16/2025	Jacobs Levy Equity Management Inc.	506,445	$12.28M	0.0%	-44.5%	0.415%
5/16/2025	Hancock Whitney Corp	38,847	$0.94M	0.0%	+1.4%	0.032%
5/16/2025	Clark Capital Management Group Inc.	244,995	$5.94M	0.0%	+17.9%	0.201%
5/16/2025	AQR Capital Management LLC	445,510	$10.80M	0.0%	-6.6%	0.365%
5/16/2025	Advisors Asset Management Inc.	178,866	$4.34M	0.1%	+7.7%	0.147%
5/16/2025	Amundi	45,131	$1.09M	0.0%	-20.3%	0.037%
5/15/2025	EP Wealth Advisors LLC	12,035	$0.29M	0.0%	+14.3%	0.010%
5/15/2025	GW Henssler & Associates Ltd.	8,481	$0.21M	0.0%	N/A	0.007%
5/15/2025	Royal Bank of Canada	213,469	$5.18M	0.0%	+39.1%	0.175%
5/15/2025	Quarry LP	8,000	$0.19M	0.0%	+60.0%	0.007%
5/15/2025	Nomura Holdings Inc.	21,083	$0.51M	0.0%	N/A	0.017%
5/15/2025	State of Wyoming	12,647	$0.31M	0.0%	-50.2%	0.010%
5/15/2025	Trexquant Investment LP	221,820	$5.38M	0.1%	+7.4%	0.182%
5/14/2025	Ieq Capital LLC	22,521	$0.55M	0.0%	+50.0%	0.018%
5/14/2025	Rafferty Asset Management LLC	104,699	$2.54M	0.0%	-10.6%	0.086%
5/14/2025	FORA Capital LLC	9,308	$0.23M	0.0%	N/A	0.008%
5/14/2025	Corebridge Financial Inc.	58,978	$1.43M	0.0%	-0.9%	0.048%
5/14/2025	Virtus Advisers LLC	22,804	$0.55M	0.7%	N/A	0.019%
5/14/2025	Freedom Investment Management Inc.	10,604	$0.26M	0.0%	-16.6%	0.009%
5/14/2025	MetLife Investment Management LLC	724,091	$17.56M	0.1%	+963.5%	0.594%
5/14/2025	Campbell & CO Investment Adviser LLC	95,079	$2.31M	0.2%	N/A	0.078%
5/14/2025	Oliver Luxxe Assets LLC	70,305	$1.71M	0.3%	+106.6%	0.058%
5/14/2025	Systematic Financial Management LP	181,390	$4.40M	0.1%	N/A	0.149%
5/14/2025	Resolute Capital Asset Partners LLC	129,356	$3.14M	1.8%	-5.9%	0.106%
5/14/2025	AlphaQuest LLC	8,589	$0.21M	0.0%	-80.4%	0.007%
5/14/2025	Advantage Alpha Capital Partners LP	20,037	$0.49M	0.1%	+53.5%	0.016%
5/14/2025	Martingale Asset Management L P	112,317	$2.72M	0.1%	+1.2%	0.092%
5/14/2025	Capital Fund Management S.A.	72,334	$1.75M	0.0%	-41.4%	0.059%
5/14/2025	EntryPoint Capital LLC	12,115	$0.29M	0.1%	N/A	0.010%
5/14/2025	BI Asset Management Fondsmaeglerselskab A S	14,248	$0.35M	0.0%	-87.8%	0.012%
5/14/2025	Hsbc Holdings PLC	34,963	$0.84M	0.0%	-3.8%	0.029%
5/14/2025	Quantbot Technologies LP	16,679	$0.40M	0.0%	+48.4%	0.014%
5/14/2025	Wellington Management Group LLP	48,447	$1.18M	0.0%	-6.0%	0.040%
5/13/2025	Northern Trust Corp	1,486,198	$36.04M	0.0%	-1.2%	1.219%
5/13/2025	Algert Global LLC	48,390	$1.17M	0.0%	+1.0%	0.040%
5/13/2025	Raymond James Financial Inc.	440,523	$10.68M	0.0%	+33.5%	0.361%
5/13/2025	Cresset Asset Management LLC	12,705	$0.31M	0.0%	N/A	0.010%
5/13/2025	Wealthedge Investment Advisors LLC	12,172	$0.30M	0.1%	N/A	0.010%
5/13/2025	American Century Companies Inc.	526,569	$12.77M	0.0%	+234.5%	0.432%
5/13/2025	Aberdeen Group plc	765,294	$18.56M	0.0%	+57.9%	0.628%
5/13/2025	Fox Run Management L.L.C.	57,118	$1.39M	0.2%	+50.4%	0.047%
5/13/2025	Boston Partners	1,275,325	$30.63M	0.0%	-1.3%	1.046%
5/13/2025	E Fund Management Co. Ltd.	9,785	$0.24M	0.0%	N/A	0.008%
5/13/2025	Russell Investments Group Ltd.	141,753	$3.44M	0.0%	-19.6%	0.116%
5/13/2025	Informed Momentum Co LLC	138,698	$3.36M	0.6%	+3.4%	0.114%
5/13/2025	HighTower Advisors LLC	81,340	$1.97M	0.0%	N/A	0.067%
5/12/2025	Knott David M Jr	212,000	$5.14M	2.4%	+1.0%	0.174%
5/12/2025	Public Sector Pension Investment Board	410,762	$9.96M	0.0%	+47.0%	0.337%
5/12/2025	Nuveen LLC	768,012	$17.19M	0.0%	N/A	0.630%
5/12/2025	Invesco Ltd.	1,199,627	$29.09M	0.0%	+41.7%	0.984%
5/12/2025	Sierra Summit Advisors LLC	26,478	$0.64M	0.1%	N/A	0.022%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	161,272	$3.91M	0.0%	N/A	0.132%
5/12/2025	Cynosure Group LLC	15,369	$0.37M	0.1%	+9.4%	0.013%
5/12/2025	Swiss National Bank	207,900	$5.04M	0.0%	-1.0%	0.170%
5/12/2025	Maryland State Retirement & Pension System	32,706	$0.79M	0.0%	-13.2%	0.027%
5/9/2025	Mutual of America Capital Management LLC	16,327	$0.40M	0.0%	-3.9%	0.013%
5/9/2025	Headlands Technologies LLC	7,737	$0.19M	0.0%	N/A	0.006%
5/9/2025	Deutsche Bank AG	186,801	$4.53M	0.0%	-6.8%	0.153%
5/9/2025	Charles Schwab Investment Management Inc.	1,326,771	$32.17M	0.0%	+6.4%	1.088%
5/9/2025	Vanguard Group Inc.	8,495,580	$206.02M	0.0%	+0.8%	6.966%
5/9/2025	Three Seasons Wealth LLC	20,324	$0.49M	0.2%	N/A	0.017%
5/9/2025	Atria Wealth Solutions Inc.	8,882	$0.22M	0.0%	N/A	0.007%
5/9/2025	PNC Financial Services Group Inc.	5,501	$0.13M	0.0%	+57.2%	0.005%
5/9/2025	Jupiter Asset Management Ltd.	488,587	$11.85M	0.1%	+1.4%	0.401%
5/9/2025	LSV Asset Management	703,802	$17.07M	0.0%	-9.4%	0.577%
5/8/2025	US Bancorp DE	7,328	$0.18M	0.0%	+17.8%	0.006%
5/8/2025	Natixis Advisors LLC	62,990	$1.53M	0.0%	+6.3%	0.052%
5/8/2025	Clark Estates Inc. NY	134,418	$3.26M	0.7%	-27.6%	0.110%
5/8/2025	Vestcor Inc	28,705	$0.70M	0.0%	+3.0%	0.024%
5/8/2025	XTX Topco Ltd	11,623	$0.28M	0.0%	-56.6%	0.010%
5/8/2025	GSA Capital Partners LLP	22,584	$0.55M	0.0%	-64.1%	0.019%

Data available starting January 2016

See Full Table

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Today's Range

Now: $21.81

$21.48

$22.06

50 Day Range

MA: $23.45

$20.75

$26.31

52 Week Range

Now: $21.81

$15.34

$26.58

Volume

1,402,938 shs

Average Volume

1,134,850 shs

Market Capitalization

$2.66 billion

P/E Ratio

13.89

Dividend Yield

N/A

Beta

0.66

Who are the company insiders with the largest holdings of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top insider shareholders include:
Steve Miller (Insider)
David S Tierney (Director)
Richard J Daly (CEO)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Alicia Grande (CFO)
Preethi Sundaram (Insider)
Carmen Jeffrey Del (Insider)
Molly Harper (Director)
Learn More about top insider investors at Catalyst Pharmaceuticals.
Who are the major institutional investors of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.09%
Juncture Wealth Strategies LLC — 0.07%
Redhawk Wealth Advisors Inc. — 0.06%
Richard P Slaughter Associates Inc — 0.05%
Wesbanco Bank Inc. — 0.05%
Wealth Enhancement Advisory Services LLC — 0.03%
Learn More about top institutional investors of Catalyst Pharmaceuticals stock.
Which major investors are selling Catalyst Pharmaceuticals stock?: During the last quarter, CPRX stock was sold by these institutional investors:
Richard P Slaughter Associates Inc
Juncture Wealth Strategies LLC
Wealth Enhancement Advisory Services LLC
BTC Capital Management Inc.
Gallacher Capital Management LLC
Within the previous year, company insiders that have sold Catalyst Pharmaceuticals company stock include:
Steve Miller (Insider)
David S Tierney (Director)
Richard J Daly (CEO)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Alicia Grande (CFO)
Preethi Sundaram (Insider)
Learn More investors selling Catalyst Pharmaceuticals stock.
Which major investors are buying Catalyst Pharmaceuticals stock?: In the last quarter, CPRX stock was acquired by institutional investors including:
Wesbanco Bank Inc.
Redhawk Wealth Advisors Inc.
Lifestyle Asset Management Inc.
Financiere des Professionnels Fonds d investissement inc.
Financiere des Professionnels Fonds d investissement inc.
Assenagon Asset Management S.A.